Ucwaningo Olusha Lokuhlola Isifo I-Alzheimer's

A BAMBA MahhalaRelease 4 | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

I-Seelos Therapeutics, Inc., inkampani ye-biopharmaceutical esesiteji somtholampilo egxile ekuthuthukisweni kwezindlela zokwelapha ukuphazamiseka kwesistimu yezinzwa kanye nezifo ezingavamile, namuhla imemezele ukuthi ithole incwadi yokuvuma ye-Clinical Trial Notification (CTN) evela eMnyangweni Wezempilo Kahulumeni wase-Australia. I-Therapeutic Goods Administration (TGA) yocwaningo lomshayeli lwe-SLS-005 (umjovo we-trehalose, 90.5 mg/mL wokufakwa emthanjeni) wokwelapha iziguli ezinesifo i-Alzheimer's. 

“Umsebenzi we-Trehalose ku-Alzheimer's uhlukile njengoba uvimbela kokubili i-beta-amyloid pathology kanye nezibalo ze-tau kumamodeli wamagundane angaphambi kwekliniki. Lo msebenzi ubonakala wenziwe nge-intraneuronal, owenzeka ngaphakathi kweseli, ohlukile ekwelashweni okugxile kumasosha omzimba. Kokubili iphrotheni eyandulela i-amyloid kanye nama-oligomers e-tau ayi-cytoplasmic ngaphakathi kweseli futhi angenziwa yi-Trehalose ngokwenza i-autophagy kanye nezinhlelo ze-proteasomal. I-Autophagy iye yathinteka ekulimazeni amanye amaphrotheni ahlanganiswe ngendlela engafanele,” kusho uRaj Mehra Ph.D., uSihlalo kanye ne-CEO yeSeelos. "Silindele ukuthola ubufakazi kanye nemininingwane ebalulekile mayelana nokufaneleka kwe-SLS-005 ekwelapheni lezi zimo zemizwa, ezilimaza kakhulu iziguli nemindeni yazo ngokomzimba, ngokomzwelo nangokwezimali."            

Ngaphezu kwalokho, u-Seelos uthole ukugunyazwa ukwenza ucwaningo lwebhasikidi olulebula elihlukile (ACTRN: 12621001755820) e-Australia ukuze kuhlolwe ukusebenza kwe-SLS-005 ekuqhubekeleni phambili kwesifo nokuqina, kanye nokuphepha nokubekezelelana kwayo, kubahlanganyeli abanezifo ezikhethiwe ze-neurodeergenerative. kuhlanganise nesifo sikaHuntington.

Umkhandlu olawulayo wase-Australia wezivivinyo zemitholampilo, i-TGA, kanye Nesikhuthazo Sentela Yocwaningo Nentuthuko sikahulumeni wase-Australia sinikeza ithuba elihle kakhulu ezinkampanini ezincane ze-biotech zase-US ukuthi ziqale izivivinyo zemitholampilo e-Australia ngomzamo wokusheshisa ukuqaliswa kwezifundo nokusebenzisa imitholampilo eqinile yezwe. amakhono esilingo.

LOKHO ONGAKUTHATHE KULESI SIHLOKO:

  • Umkhandlu olawulayo wase-Australia wezivivinyo zemitholampilo, i-TGA, kanye Nesikhuthazo Sentela Yocwaningo Nentuthuko sikahulumeni wase-Australia sinikeza ithuba elihle kakhulu ezinkampanini ezincane ze-biotech zase-US ukuthi ziqale izivivinyo zemitholampilo e-Australia ngomzamo wokusheshisa ukuqaliswa kwezifundo nokusebenzisa imitholampilo eqinile yezwe. amakhono esilingo.
  • , inkampani ye-biopharmaceutical yesigaba somtholampilo egxile ekuthuthukisweni kwezindlela zokwelapha ukuphazamiseka kwesistimu yezinzwa kanye nezifo ezingavamile, namuhla imemezele ukuthi ithole incwadi yokuvuma ye-Clinical Trial Notification (CTN) evela eMnyangweni KaHulumeni wase-Australia Wezempilo YokuPhathwa Kwempahla Yokwelapha (TGA). ) ocwaningweni lomshayeli we-SLS-005 (umjovo we-trehalose, 90.
  • 12621001755820) e-Australia ukuhlola ukusebenza kwe-SLS-005 ekuqhubekeleni phambili kwesifo nokuqina, kanye nokuphepha nokubekezelelana kwayo, kubahlanganyeli abanezifo ezikhethiwe ze-neurodeergenerative kuhlanganise nesifo sika-Huntington.

<

Mayelana umbhali

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...